Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Capricor Therapeutics, Inc. - Common Stock (NQ:CAPR)

7.560 +0.320 (+4.42%)
Delayed Quote Updated: 10:21 AM EST, Nov 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Capricor Therapeutics, Inc. - Common Stock

< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
News headline image
IGM Biosciences, CPI Card And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Here's How Much $100 Invested In Capricor Therapeutics 5 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
Prime Medicine, MINISO Group, Li Auto, Weibo And Other Big Stocks Moving Higher On Monday ↗
 
Via Benzinga
News headline image
Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher
Capricor Therapeutics Inc. (NASDAQ: CAPR) is a biotechnology firm focused on developing cell and exosome-based treatments for rare diseases like iomyopathy 
Via MarketBeat
News headline image
Deep Dive Into Capricor Therapeutics Stock: Analyst Perspectives (5 Ratings) ↗
 
Via Benzinga
News headline image
Unveiling 6 Analyst Insights On Capricor Therapeutics ↗
 
Via Benzinga
News headline image
Dow Tumbles Over 200 Points; CERo Therapeutics Shares Jump ↗
 
Via Benzinga
Topics Stocks
News headline image
Crude Oil Down Over 1%; Stitch Fix Shares Plummet ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
 
Via Benzinga
News headline image
Hewlett Packard Enterprise, Nvidia, Progress Software And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
Nvidia, Alibaba, Capricor Therapeutics, TSMC, Tesla: Why These 5 Stocks Are On Investors' Radars Today ↗
On Tuesday, major U.S. indices closed higher, with the Dow Jones Industrial Average gaining 0.2% to reach 42,208.22. 
Via Benzinga
Topics Stocks
News headline image
What's Going On With Capricor Therapeutics Stock Friday? ↗
The biotechnology company said deramiocel increased cardiac function based on several different measures. 
Via Benzinga
News headline image
Expert Ratings For Capricor Therapeutics ↗
 
Via Benzinga
News headline image
Why Capricor Therapeutics Stock Is Soaring Tuesday ↗
Capricor Therapeutics Inc (NASDAQ:CAPR) shares are trading higher Tuesday after the company announced intent to file a biologics license application (BLA) for the full approval of Deramiocel for the... 
Via Benzinga
News headline image
Week In Review: Nippon Shinyaku Signs $735 Million Deal For DMD Therapy ↗
Japan’s Nippon Shinyaku will acquire European rights for a Duchenne muscular dystrophy disease therapy developed by Capricor Therapeutics of San Diego. Nippon Shinyaku will pay $20 million upfront and... 
Via Talk Markets
News headline image
EXCLUSIVE: Capricor Therapeutics Inks European Expansion, Commercialization Pact For Lead Asset With Japanese Pharma Firm ↗
Capricor Therapeutics partners with Nippon Shinyaku for the European commercialization of Duchenne muscular dystrophy treatment, deramiocel, with a potential $1.5 billion in milestone payments from... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
What's Going On With Capricor Therapeutics Stock Tuesday? ↗
Capricor Therapeutics announced successful completion of a Type-B meeting with the U.S. Food and Drug Administration (FDA). 
Via Benzinga
News headline image
Recap: Capricor Therapeutics Q4 Earnings ↗
 
Via Benzinga
News headline image
Earnings Scheduled For February 29, 2024 ↗
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. 
Via Benzinga
News headline image
Capricor Therapeutics's Earnings Outlook ↗
 
Via Benzinga
News headline image
Preview: Capricor Therapeutics's Earnings ↗
 
Via Benzinga
News headline image
What's Going On With Capricor Therapeutics Stock Tuesday? ↗
Capricor Therapeutics, Inc. (NASDAQ: CAPR) is trading higher Tuesday after the company announced three-year results from the ongoing HOPE-2 open-label extension 
Via Benzinga
News headline image
CAPR Stock Earnings: Capricor Therapeutics Misses EPS, Misses Revenue for Q1 2024 ↗
CAPR stock results show that Capricor Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
FlexShopper And 3 Other Penny Stocks Insiders Are Buying ↗
The Dow Jones closed higher by around 65 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
News headline image
Cadrenal Therapeutics And 3 Other Stocks Under $3 Insiders Are Buying ↗
The Dow Jones closed higher by around 290 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
News headline image
US Stocks Turn Lower; Dow Tumbles Over 200 Points ↗
U.S. stocks turned lower toward the end of trading, with the Dow Jones falling over 200 points on Friday. The Dow traded down 0.70% to 33,432.17 while the NASDAQ fell 0.15% to 13,181.22. The S&P 500... 
Via Benzinga
Topics Stocks
News headline image
Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Gainers Blue Apron Holdings, Inc. (NASDAQ: APRN) climbed 133.5% to $12.82 after the company announced an agreement to be acquired by Wonder Group for $13 per share. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.